http://ideas.eyeconx.net/story.php?title=nice-recommends-lucentis-ranibizumab-for-some-patients-with-visual-impairment-due-to-diabetic-macular-oedema The National Institute for Health and Clinical Excellence (NICE) has today issued positive draft guidance on the use of ranibizumab for the treatment of VI-DMO, an eye condition which can occur in people with diabetes that causes blurred vision, severe vision loss and sometimes blindness. This means that some patients (those with a retinal thickness of 400 micrometres or more), could soon benefit ... Mon, 26 Nov 2012 14:44:00 EST en